AzTrials
AzTrials

Uterine RuptureNCT04566705

Uterine Rupture During Labor Among Women With a Prior Cesarean Delivery

An observational study of Uterine Rupture and Mode of Delivery, run by University Hospital, Montpellier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Although a rare event, uterine rupture during labour is one of the most serious obstetric complications because of the dramatic maternal-fetal consequences that can result. Identifying the risk factors associated with uterine rupture would enable gynecologists to provide patients with risks of uterine rupture in the… Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Uterine Rupture, Mode of Delivery
What is being tested?
Risks factors, maternal and neonatal outcomes/complications
How many people
95 participants
Where
1 siteFrance
Study dates
1 Mar 2020to 1 Apr 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Women with uterine rupture after previous cesarean delivery versus women without uterine rupture after previous cesarean delivery

Who may be able to join

  • Singleton pregnancy > 24 weeks of gestation
  • Second or multiparous with a previous cesarean section without vaginal delivery since
  • Cephalic presentation or completed breech
  • Uterine rupture during labor

Who cannot join

  • Incomplete uterine rupture
  • Multiple gestation
  • Transverse presentation or complete breech
  • Vaginal delivery after cesarean
  • Non-low transverse cesarean section
  • Placenta praevia
  • Antepartum intrauterine fetal death
  • History of uterine surgery (myomectomy)

Trial locations and contacts

1 site in 1 country.

France1 site
  • Uhmontpellier

    Montpellier, 34295

Other trials in France

About this study

Official title: Uterine Rupture During Labor Among Women With a Prior Cesarean Delivery : Risks Factors, Maternal and Perinatal Outcomes

Although a rare event, uterine rupture during labour is one of the most serious obstetric complications because of the dramatic maternal-fetal consequences that can result.

Identifying the risk factors associated with uterine rupture would enable gynecologists to provide patients with risks of uterine rupture in the event of attempted vaginal delivery.

The aim of our study is to determine risks factors for uterine rupture during labour in patients with a previous cesarean delivery who have not given birth since and to assess the occurrence of maternal-fetal comply-cations compared to patients with a previous cesarean delivery without uterine rupture.

Being tested
Risks factors, maternal and neonatal outcomes/complications
Keywords
Risks factors, Uterine rupture after a previous cesarean delivery, Vaginal birth after cesarean, Prior cesarean, Perinatal outcome
Medical subject headings
Uterine Rupture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Risks factors, maternal and neonatal outcomes/complicationsOther

    Risks factors, maternal and neonatal outcomes/complications

Study groups in NCT04566705
Study groupRoleWhat they receive
Women with uterine ruptureWomen with uterine rupture
Women without uterine ruptureWomen without uterine rupture
Receives: Other: Risks factors, maternal and neonatal outcomes/complications

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assess the risks factors of uterine rupture

    Assess the risks factors of uterine rupture

    Assess the risks factors of uterine rupture using obstetric measures

    Measured: 1 day

Secondary outcomes (1)
  1. Number of Participants with Assess the maternal and perinatal complications and outcomes

    Number of Participants withAssess the maternal and perinatal complications and outcomes : looking for maternal complications (chorioamnionitis , transfusion, post-partum hemorrhage, surgery for blad-der wound, maternal death,…) and neonatal comply-cations (apgar<7 at 5minutes, pH <7,15, neonatal intein-sive care unit and perinatal death)

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2020
  2. Study start1 Mar 2020
  3. Primary completion30 Mar 2020
  4. Study completion1 Apr 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
95 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04566705
Sponsor's protocol ID
RECHMPL20_0142
Status last verified
Sep 2020
First submitted
14 Sep 2020
Last updated
18 Nov 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: NC

Questions about this trial

What is this clinical trial studying?

An observational study of Uterine Rupture and Mode of Delivery, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assess the risks factors of uterine rupture (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in